Oakes Gregory
Insider CIK 1809796 · AZRX Director · LABP Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LABP Landos Biopharma, Inc. | D To issuer deriv | 2024-05-23 | 2024-05-23 | 167,724 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | D To issuer deriv | 2024-05-23 | 2024-05-23 | 47,529 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | D To issuer deriv | 2024-05-23 | 2024-05-23 | 54,454 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 54,454 | — | $0 | 54,454 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2023-02-28 | 2023-03-02 | 475,300 | — | $0 | 475,300 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2022-06-20 | 2022-06-22 | 1,677,251 | — | $0 | 1,677,251 | SEC↗ |
| FWBI First Wave BioPharma, Inc. | A Award deriv | 2022-01-03 | 2022-01-03 | 34,482 | — | $0 | 34,482 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 41,237 | — | $0 | 41,237 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award deriv | 2020-04-13 | 2020-04-16 | 60,000 | — | $0 | 60,000 | SEC↗ |